New article: What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib https://t.co/IMH71frE03 #prostatecancer #oncology https://t.co/OD7RPHNPtV
906 followers
17,936 followers
What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib: Background The poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib was #oncology… https://t.co/X
6,544 followers
New research: What Plasma Can Tell Us When Tissue Cannot: A Case Report of Genomic Testing in mCRPC and Clinical Response to Treatment With the PARP Inhibitor Rucaparib: Background The poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib was… https://t.